Literature DB >> 7990064

Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes.

A M Fontana1, T G Palfai.   

Abstract

Relationships between event content of daily stressors, appraisal of daily stressors, coping processes, and menstrual cycle phase were examined in women with premenstrual dysphoria (PMD) and controls. Seventy-eight women completed the Daily Rating Form, the Daily Coping Scale and the Multiple Affect Adjective Checklist-Revised on a daily basis during the premenstrual and postmenstrual phases. No premenstrual-postmenstrual differences in frequency of occurrence of stressors were reported. Academic and interpersonal stressors were the most frequently reported stressors during both cycle phases. PMD women appraised daily stressors as being more stressful, undesirable, and changeable premenstrually than postmenstrually as compared to controls. Catharsis was used more frequently premenstrually as compared to postmenstrually by PMD women. Premenstrually, women with PMD sought social support more frequently than controls. Interactive relationships between appraisal and coping style varied as a function of cycle phase for PMD women. A state-dependent model of menstrual-related mood changes is supported.

Entities:  

Mesh:

Year:  1994        PMID: 7990064     DOI: 10.1016/0022-3999(94)90053-1

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

1.  Exposure to American culture is associated with premenstrual dysphoric disorder among ethnic minority women.

Authors:  Corey E Pilver; Stanislav Kasl; Rani Desai; Becca R Levy
Journal:  J Affect Disord       Date:  2010-11-05       Impact factor: 4.839

2.  Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder.

Authors:  Corey E Pilver; Becca R Levy; Daniel J Libby; Rani A Desai
Journal:  Arch Womens Ment Health       Date:  2011-07-23       Impact factor: 3.633

3.  Lifetime discrimination associated with greater likelihood of premenstrual dysphoric disorder.

Authors:  Corey E Pilver; Rani Desai; Stanislav Kasl; Becca R Levy
Journal:  J Womens Health (Larchmt)       Date:  2011-06       Impact factor: 2.681

4.  Psychosocial Profile of Women with Premenstrual Syndrome and Healthy Controls: A Comparative Study.

Authors:  Maria Kleinstäuber; Katarina Schmelzer; Beate Ditzen; Gerhard Andersson; Wolfgang Hiller; Cornelia Weise
Journal:  Int J Behav Med       Date:  2016-12

5.  Health advantage for black women: patterns in pre-menstrual dysphoric disorder.

Authors:  C E Pilver; S Kasl; R Desai; B R Levy
Journal:  Psychol Med       Date:  2010-11-26       Impact factor: 7.723

6.  Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Authors:  C Neill Epperson; Meir Steiner; S Ann Hartlage; Elias Eriksson; Peter J Schmidt; Ian Jones; Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

Review 7.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285

8.  Ways of coping with premenstrual change: development and validation of a premenstrual coping measure.

Authors:  Jennifer R Read; Janette Perz; Jane M Ussher
Journal:  BMC Womens Health       Date:  2014-01-03       Impact factor: 2.809

9.  Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial.

Authors:  Jane M Ussher; Janette Perz
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

10.  How Do Elite Female Athletes Cope with Symptoms of Their Premenstrual Period? A Study on Rugby Union and Football Players' Perceived Physical Ability and Well-Being.

Authors:  Roberto Modena; Elisa Bisagno; Federico Schena; Simone Carazzato; Francesca Vitali
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.